Evidence map›Paper›PMID 18758472›Full record

ReviewNature reviews. Drug discovery2008

Targeting of tetraspanin proteins--potential benefits and strategies.

Martin E Hemler

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Drug discovery, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 197 papers.

0numbers the graph read from it
0cells of the map it votes in
197citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

197 citing papers in PubMed, 341 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Force spectroscopy reveals membrane fluctuations and surface adhesion of extracellular nanovesicles impact their elastic behavior.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

137 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Martin E HemlerDana-Farber Cancer Institute, 44 Binney Street, Boston, Massachussetts 02115, USA. Martin_Hemler@dfci.harvard.edu
Dana-Farber/Harvard Cancer Center · US

Funding

Support of carcinoma metastasis by integrin a6-CD151-PKC complexesR01CA042368 · NCI · DANA-FARBER CANCER INSTITUTE · PI HEMLER, MARTIN E · 1986 to 2019
$5.4M
TRANSMEMBRANE LINKER FUNCTIONS OF TM4SF PROTEINSR01GM038903 · NIGMS · DANA-FARBER CANCER INSTITUTE · PI HEMLER, MARTIN E · 1987 to 2011
$3.7M
NCI NIH HHS CA42368NCI NIH HHS R01 CA042368NIGMS NIH HHS GM38903NIGMS NIH HHS R01 GM038903
6 · The paper itself

Abstract

The tetraspanin transmembrane proteins have emerged as key players in malignancy, the immune system, during fertilization and infectious disease processes. Tetraspanins engage in a wide range of specific molecular interactions, occurring through the formation of tetraspanin-enriched microdomains (TEMs). TEMs therefore serve as a starting point for understanding how tetraspanins affect cell signalling, adhesion, morphology, motility, fusion and virus infection. An abundance of recent evidence suggests that targeting tetraspanins, for example, by monoclonal antibodies, soluble large-loop proteins or RNAi technology, should be therapeutically beneficial.

Indexed as

Drug Delivery SystemsAnimalsAntibodies, MonoclonalHumansMembrane MicrodomainsMembrane ProteinsProteinsRNA InterferenceSignal TransductionAntibodies, MonoclonalMembrane ProteinsProteins

Identifiers

PMID18758472
PMCPMC4737550
OpenAlexW1967427925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.